ZEVIPTO
LIVE

Serial Number

79291284

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jun 30, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ZEVIPTO Trademark

Serial Number: 79291284 • Registration: 6224682

ZEVIPTO is a trademark filed by NOVARTIS AG on June 30, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

June 30, 2020

Registration Date

December 22, 2020

Published for Opposition

October 6, 2020

Cancellation Date

August 14, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sep 3, 2024 DENA
DEATH OF INTERNATIONAL REGISTRATION
Sep 3, 2024 DETH
INTERNATIONAL REGISTRATION RENEWED
Dec 22, 2023 RNWL
NOTIFICATION PROCESSED BY IB
Feb 28, 2021 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Feb 6, 2021 FICS
FINAL DISPOSITION PROCESSED
Feb 5, 2021 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jan 21, 2021 GPAR
REGISTERED-PRINCIPAL REGISTER
Dec 22, 2020 R.PR
NOTIFICATION PROCESSED BY IB
Oct 24, 2020 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 6, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 6, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 30, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 30, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 16, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 2, 2020 CNSA
ASSIGNED TO EXAMINER
Sep 1, 2020 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 25, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 25, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 25, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 25, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 25, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 25, 2020 COAR
APPLICATION FILING RECEIPT MAILED
Aug 22, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 18, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 17, 2020 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Aug 6, 2020 SDRC